Gregory Norden is the former Chief Financial Officer of Wyeth and has been a member of our board since January 2013. Mr. Norden also serves on the boards of NanoString Technologies, a leading provider of life science tools for translational research; Praxis, a clinical stage biopharmaceutical company; and Royalty Pharma, a leading funder of innovation across the biopharmaceutical industry. Mr. Norden is a former director of Human Genome Sciences, Univision and Welch Allyn. In addition, Mr. Norden is the Managing Director of G9 Capital Group LLC, which invests in early-stage ventures and provides corporate finance advisory services.